medigraphic.com
ISSN 1561-2929 (Print)

2015, Number 2

<< Back Next >>

RCAN 2015; 25 (2)

Contenido de oxalato en los preparados de plantas medicinales utilizadas en el tratamiento de las urolitiasis

Bacallao MRA, Mañalich CR, Caldevilla RY, Badell MA

Language: Spanish
References: 17
Page: 405-410
PDF size: 292.75 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Seitz C, Fajkovic H. Epidemiological gender-specific aspects in urolithiasis. World J Urol 2013;31:1087-92.

  2. Reyes L, Mirabal M, Mañalich R, Almaguer M. Estudio comparativo del comportamiento clínico epidemiológico de la urolitiasis en dos poblaciones diferentes de Cuba. Rev Port Nefrol Hipert 2004;18:155-65.

  3. Curhan GC, Taylor EN. 24-h uric acid excretion and the risk of kidney stones. Kidney Int 2008;73:489.

  4. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 2001;59:270.

  5. Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol 2007;18:2198.

  6. Siener R, Ebert D, Nicolay C, Hesse A. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int 2003;63:1037.

  7. Curhan GC. Risk factors for calcium stones in adults En: UpToDate [Editor: Basow DS]. UpToDate. Waltham MA: 2013.

  8. Bacallao Méndez RA, Madrid Mancia C, Mañalich Comas R, Gutiérrez García F, Badell Moore A. Trastornos metabólicos renales en pacientes cubanos adultos con litiasis urinarias. Rev Cubana Med 2014; 53(4):456-67. Disponible en: http://scielo.sld.cu/scielo.php?script=sci _arttext&pid=S0034- 75232014000400009&lng=es. Fecha de última visita: 24 de Octubre del 2015.

  9. Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 2007; 177:565.

  10. McConnell N, Campbell S, Gillanders I. Risk factors for developing renal stones in inflammatory bowel disease. BJU Int 2002;89:835.

  11. Hoppe B, von Unruh GE, Blank G. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis. Am J Kidney Dis 2005;46:440.

  12. Kaufman DW, Kelly JP, Curhan GC. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 2008;19:1197.

  13. Gambaro G, Petrarulo M, Nardelotto A. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis. Kidney Int 1995;48:1549.

  14. Jiang Z, Asplin JR, Evan AP. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet 2006; 38:474.

  15. Hoppe B, Langman CB. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 2003;18:986.

  16. Urivetzky M, Kessaris D, Smith AD. Ascorbic acid overdosing: A risk factor for calcium oxalate nephrolithiasis. J Urol 1992;147:1215.

  17. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: New insights after 14 years of follow-up. J Am Soc Nephrol 2004;15:3225.




2020     |     www.medigraphic.com